Vivekanand Jha's Publications

About Vivekanand Jha's Publications

Executive Director, The George Institute for Global Health, India
  • MD,
  • DM,
  • FRCP,
  • FAMS
  • The Case | Reversible rapidly progressive renal failure with loss of vision

    Kidney International Date published:
  • Spectrum of lymphoproliferative disorders following renal transplantation in North India

    Indian Journal of Nephrology Date published:
  • Chronic kidney disease: global dimension and perspectives

    The Lancet Date published:
  • Organ Trafficking and Transplant Tourism

    Transplantation Date published:
  • The price of a QALY-cost-effectiveness of statins in CKD

    Nature Reviews Nephrology Date published:
  • Sa1351 Neutrophil Gelatinase-Associated Lipocalin: An Early Biomarker for Predicting Acute Kidney Injury in Patients With Acute Pancreatitis

    Gastroenterology Date published:
  • Peritoneal Dialysis: The Great Savior during Disasters

    Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis Date published:
  • Current status of end-stage renal disease care in India and Pakistan

    Kidney International Supplements Date published:
  • IgG4-related tubulointerstitial nephritis presenting with psychiatric manifestations and skin lesions

    International Urology and Nephrology Date published:
  • 1134 GRADE ASSOCIATED AUTOPHAGY REGULATION VIA AMPK AND MTOR CONTRIBUTES TO UROTHELIAL CANCER CELL SURVIVAL

    Journal of Urology Date published:
  • Community-acquired acute kidney injury in tropical countries

    Nature Reviews Nephrology Date published:
  • Letters to the Editor

    Journal of the American Veterinary Medical Association Date published:
  • ACUTE KIDNEY INJURY: AN INDIAN STUDY

    Date published:
  • EMPHYSEMATOUS PYELONEPHRITIS IN TYPE 2 DIABETES MELLITUS PATIENTS: A PROSPECTIVE STUDY

    Date published:
  • NGAL-A new biomarker predicting persistent AKI and severe acute pancreatitis (SAP), a case control study

    Date published:
  • RENAL ALLOGRAFT OUTCOMES IN LIVE DONOR RECIPIENTS ON TACROLIMUS BASED TRIPLE IMMUNOSUPPRESSION WITH AND WITHOUT BASILIXIMAB INDUCTION

    Date published: